Clinical trial

A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the…

NCT00203190 · Thomas Jefferson University, Other · Terminated

Key facts

NCT number NCT00203190
Title A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache
Official title A Single-Center, Randomized, Double-Blind, Placebo Controlled Trial Examining the Safety and Efficacy of Topiramate in the Treatment of Subjects With Episodic or Chronic Cluster Headache.
Lead sponsor Thomas Jefferson University, Other
Collaborators Ortho-McNeil Neurologics, Inc. Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Cluster Headache
Intervention type Drug
Interventions Topiramate
Enrollment 60
Start date Sep 1, 2004
Completion Jun 1, 2006
First posted Sep 20, 2005
Last update posted Jan 23, 2009
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies